Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1 shares at $747.00 ($747) on 2023-01-27, disclosed to the SEC on 2023-01-30.
Scheduled sale ($747) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |